Drug Shortage Report for ARZERRA
Report ID | 4096 |
Drug Identification Number | 02381559 |
Brand name | ARZERRA |
Common or Proper name | ARZERRA 100MG VIALS |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | Ofatumumab |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ML X 3 |
ATC code | L01XC |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-08-01 |
Actual start date | 2017-09-21 |
Estimated end date | |
Actual end date | 2018-09-26 |
Shortage status | Resolved |
Updated date | 2018-10-17 |
Company comments | Being assessed for discontinuation - communication to follow |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2018-10-17 | French | Compare |
v16 | 2018-10-17 | English | Compare |
v15 | 2018-10-17 | English | Compare |
v14 | 2018-10-17 | English | Compare |
v13 | 2018-10-17 | English | Compare |
v12 | 2018-09-27 | English | Compare |
v11 | 2018-09-26 | French | Compare |
v10 | 2018-09-26 | English | Compare |
v9 | 2018-09-26 | French | Compare |
v8 | 2018-09-26 | English | Compare |
v7 | 2018-09-26 | English | Compare |
v6 | 2017-11-30 | French | Compare |
v5 | 2017-11-30 | English | Compare |
v4 | 2017-08-02 | English | Compare |
v3 | 2017-03-23 | French | Compare |
v2 | 2017-03-23 | English | Compare |
v1 | 2017-03-23 | English | Compare |
Showing 1 to 17 of 17